|
| Exchange Disseminated Time 27/06/2016 16:53:39 | Alkem Laboratories Ltd has informed BSE regarding in relation to certain restructuring of responsibilities between the senior management of the Company.
The Joint Managing Directors and Executive Director would be responsible for the following functional areas of the Company’s business:
- Mr. Dhananjay Kumar Singh, Joint Managing Director, shall be responsible for specific Domestic Business units focusing on Acute and Chronic Therapies in addition to support functions namely Legal and Secretarial, Purchase, Distribution & Logistics and Human Resources.
- Mr. Sandeep Singh, Joint Managing Director, shall be responsible for International Business, R & D including Biotech, Finance, Quality & Compliance, API and Formulation Manufacturing facilities for International Business.
- Mr. Mritunjay Kumar Singh, Executive Director, shall be responsible for certain Domestic Business units focusing on Acute and Chronic Therapies, Generics and Healthcare in addition to Strategy & Business Development and Manufacturing Facilities for Domestic Business.
- Mr. Dhananjay Kumar Singh, Mr. Sandeep Singh and Mr. Mritunjay Kumar Singh shall report to Executive Chairman for their respective functional areas of business.
- Mr. Prabhat Agrawal, Chief Executive Officer, shall be responsible for the overall day to day operations of the Company and report to Mr. Dhananjay Kumar Singh, Mr. Sandeep Singh and Mr. Mritunjay Kumar Singh for their abovesaid respective roles and responsibilities.
The above mentioned changes will be made with immediate effect. |
|
|